On episode 30 of PSQH: The Podcast, Niall O’Connor, chief technology officer of Cohere Health, talks about using AI and machine learning to improve patient care.
A technology leader in the healthcare and life sciences spaces, O’Connor most recently was chief technology officer for Genospace, a cloud-based software company focused on delivering personalized medicine. He was a member of the founding team at Genospace and also held software engineering positions at Dana-Farber Cancer Institute and Fidelity Investments. O’Connor earned a B.E. in electronics and computers from National University of Ireland, Galway, and attended the Executive Education Program at the Wharton School of University of Pennsylvania.
Share:
About the Author: Cohere Health
Cohere Health is a clinical intelligence company that provides intelligent prior authorization as a springboard to better quality outcomes by aligning physicians and health plans on evidence-based care paths for the patient's entire care journey. Currently processing nine million intelligent prior authorization requests annually, Cohere positively impacts more than 15 million health plan members and 492,000 healthcare providers nationwide. The company is a Top 5 LinkedIn™ Startup, winner of the TripleTree iAward, three-time recipient of KLAS Research's Points of Light, and has been named to Fierce Healthcare's Fierce 15 and CB Insights' Digital Health 150 lists. Cohere's investors include Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners.
